Although artificial intelligence (AI) has existed for decades, recent advances in computational power, data availability, and machine learning models have significantly accelerated its development and expanded its practical applications. Nowhere is this rapid evolution more apparent than in the field of healthcare, where AI is transforming how we understand, diagnose, and treat medical conditions. Today, AI systems play an increasingly vital role in accelerating the discovery of new therapeutics and medical devices, streamlining clinical workflows, and enhancing the accuracy and timeliness of diagnoses and treatment recommendations. Panelists will discuss their contributions to the global regulatory AI framework, share insights from the regional AI evaluations, and explore the broader implications for global health governance. The session will also examine cross-cutting themes such as emerging regulatory trends, critical legislative gaps, and opportunities to harmonize policy approaches across borders. Attendees will gain a unique opportunity to hear from those at the forefront of global efforts to align AI innovation with robust, equitable, and future-ready regulatory systems.